| Potential role of bioactive peptides in prevention and treatment of chronic diseases: A narrative review AFG Cicero, F Fogacci, A Colletti British journal of pharmacology 174 (11), 1378-1394, 2017 | 315 | 2017 |
| PCSK9 induces a pro-inflammatory response in macrophages C Ricci, M Ruscica, M Camera, L Rossetti, C Macchi, A Colciago, I Zanotti, ... Scientific reports 8 (1), 2267, 2018 | 206 | 2018 |
| Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled … AFG Cicero, A Sahebkar, F Fogacci, M Bove, M Giovannini, C Borghi European journal of nutrition 59, 477-483, 2020 | 177 | 2020 |
| Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials S Fogacci, F Fogacci, M Banach, ED Michos, AV Hernandez, GYH Lip, ... Clinical Nutrition 39 (6), 1742-1752, 2020 | 162 | 2020 |
| Safety and tolerability of available urate-lowering drugs: a critical review L Strilchuk, F Fogacci, AF Cicero Expert Opinion on Drug Safety 18 (4), 261-271, 2019 | 160 | 2019 |
| Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach AFG Cicero, F Fogacci, A Colletti Food & function 8 (6), 2076-2088, 2017 | 159 | 2017 |
| Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials F Fogacci, G Tocci, V Presta, A Fratter, C Borghi, AFG Cicero Critical reviews in food science and nutrition 59 (10), 1605-1618, 2019 | 143 | 2019 |
| Efficacy and safety of mipomersen: a systematic review and meta-analysis of randomized clinical trials F Fogacci, N Ferri, PP Toth, M Ruscica, A Corsini, AFG Cicero Drugs 79, 751-766, 2019 | 130 | 2019 |
| Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study AFG Cicero, F Fogacci, M Giovannini, E Grandi, M Rosticci, S D’Addato, ... Scientific reports 8 (1), 1-6, 2018 | 114 | 2018 |
| Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials F Fogacci, M Banach, DP Mikhailidis, E Bruckert, PP Toth, GF Watts, ... Pharmacological research 143, 1-16, 2019 | 108 | 2019 |
| High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects AFG Cicero, M Rosticci, F Fogacci, E Grandi, S D'Addato, C Borghi, ... European journal of internal medicine 37, 38-42, 2017 | 107 | 2017 |
| Red yeast rice for hypercholesterolemia AFG Cicero, F Fogacci, M Banach Methodist DeBakey cardiovascular journal 15 (3), 192, 2019 | 100 | 2019 |
| Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial AFG Cicero, F Fogacci, M Bove, M Giovannini, C Borghi European journal of nutrition 60, 655-663, 2021 | 95 | 2021 |
| A randomized placebo-controlled clinical trial to evaluate the medium-term effects of oat fibers on human health: the beta-glucan effects on lipid profile, glycemia and … AFG Cicero, F Fogacci, M Veronesi, E Strocchi, E Grandi, E Rizzoli, A Poli, ... Nutrients 12 (3), 686, 2020 | 89 | 2020 |
| Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar AFG Cicero, F Fogacci, A Zambon Journal of the American College of Cardiology 77 (5), 620-628, 2021 | 81 | 2021 |
| COVID-19-related quarantine effect on dietary habits in a northern Italian rural population: data from the Brisighella Heart Study AFG Cicero, F Fogacci, M Giovannini, M Mezzadri, E Grandi, C Borghi, ... Nutrients 13 (2), 309, 2021 | 81 | 2021 |
| Circulating levels of proprotein convertase subtilisin/kexin type 9 and arterial stiffness in a large population sample: data from the Brisighella Heart Study M Ruscica, N Ferri, F Fogacci, M Rosticci, M Botta, S Marchiano, P Magni, ... Journal of the American Heart Association 6 (5), e005764, 2017 | 81 | 2017 |
| Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels? AFG Cicero, F Fogacci, AP Stoian, M Vrablik, K Al Rasadi, M Banach, ... Current atherosclerosis reports 23, 1-14, 2021 | 78 | 2021 |
| Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update AFG Cicero, F Fogacci, M Kuwabara, C Borghi Medicina 57 (1), 58, 2021 | 77 | 2021 |
| Clinical effects of xanthine oxidase inhibitors in hyperuricemic patients AFG Cicero, F Fogacci, RI Cincione, G Tocci, C Borghi Medical principles and practice 30 (2), 122-130, 2021 | 73 | 2021 |
Arrigo Francesco Giuseppe CiceroProfessore Asssociato, Università di BolognaEmail verificata su unibo.it
